These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7539507)

  • 21. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.
    Russell RR; Bowmer MI; Nguyen C; Grant MD
    Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
    DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
    Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
    Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
    J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes.
    Lee S; Goldstein H; Baseler M; Adelsberger J; Golding H
    J Virol; 1997 Sep; 71(9):6671-6. PubMed ID: 9261389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation.
    Tang S; Patterson B; Levy JA
    J Virol; 1995 Sep; 69(9):5659-65. PubMed ID: 7637012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.
    Chun TW; Finzi D; Margolick J; Chadwick K; Schwartz D; Siliciano RF
    Nat Med; 1995 Dec; 1(12):1284-90. PubMed ID: 7489410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Ip S; Munier ML; Kaufmann DE; Suzuki K; Brereton C; Sasson SC; Seddiki N; Koelsch K; Landay A; Grey P; Finlayson R; Kaldor J; Rosenberg ES; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD
    J Virol; 2006 Oct; 80(20):10162-72. PubMed ID: 17005693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains.
    Yelle J; Morisset R; Thibodeau L
    Arch Virol; 1994; 139(1-2):155-72. PubMed ID: 7826207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
    Chen BK; Gandhi RT; Baltimore D
    J Virol; 1996 Sep; 70(9):6044-53. PubMed ID: 8709227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4
    Grau-Expósito J; Serra-Peinado C; Miguel L; Navarro J; Curran A; Burgos J; Ocaña I; Ribera E; Torrella A; Planas B; Badía R; Castellví J; Falcó V; Crespo M; Buzon MJ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.
    Zachar V; Spire B; Hirsch I; Chermann JC; Ebbesen P
    J Virol; 1991 Apr; 65(4):2102-7. PubMed ID: 1705998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
    Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
    J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.
    Popik W; Pitha PM
    J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
    Bachelder RE; Bilancieri J; Lin W; Letvin NL
    J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.